Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
Centre for Cardiovascular Genomics and Medicine (CCGM), Lui Che Woo Institute Innovative Medicine, Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
Zool Res. 2023 May 18;44(3):591-603. doi: 10.24272/j.issn.2095-8137.2022.487.
Large animal models of cardiac ischemia-reperfusion are critical for evaluation of the efficacy of cardioprotective interventions prior to clinical translation. Nonetheless, current cardioprotective strategies/interventions formulated in preclinical cardiovascular research are often limited to small animal models, which are not transferable or reproducible in large animal models due to different factors such as: (i) complex and varied features of human ischemic cardiac disease (ICD), which are challenging to mimic in animal models, (ii) significant differences in surgical techniques applied, and (iii) differences in cardiovascular anatomy and physiology between small versus large animals. This article highlights the advantages and disadvantages of different large animal models of preclinical cardiac ischemic reperfusion injury (IRI), as well as the different methods used to induce and assess IRI, and the obstacles faced in using large animals for translational research in the settings of cardiac IR.
大型动物心脏缺血再灌注模型对于评估心脏保护干预措施的疗效至关重要,这些干预措施在临床转化之前需要进行评估。尽管如此,目前在临床前心血管研究中制定的心脏保护策略/干预措施通常仅限于小动物模型,由于以下因素,这些策略/干预措施在大型动物模型中不可转移或不可复制:(i)人类缺血性心脏病(ICD)的复杂和多样化特征,这些特征在动物模型中难以模拟,(ii)应用的手术技术存在显著差异,以及(iii)小型与大型动物之间心血管解剖和生理学的差异。本文重点介绍了不同的临床前心脏缺血再灌注损伤(IRI)大型动物模型的优缺点,以及诱导和评估 IRI 所使用的不同方法,以及在心脏 IR 背景下使用大型动物进行转化研究所面临的障碍。